are glp 1 injections safe GLP-1 Agonists: A Comprehensive Overview GLP-1 Injections for Medical Weight

A mechanistic guide to this next-generation metabolic peptide.

LillyDirect now $299-449/mo

The global incretin-based drugs market was valued at USD 39.4 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 72.6 billion by 2035, expanding at a CAGR of 6.4% between 2026 and 2035, driven by the rising prevalence of type 2 diabetes mellitus.

GLP-1 therapy doesn't require expensive brand names or insurance coverage

Given the potential for increased INR variability, clinicians may consider increasing INR monitoring frequency following GLP-1 RA initiation.

Are GLP-1 & weight loss drugs covered by insurance